Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema

Asociación para Evitar la Ceguera en México

Status and phase: Terminated; Phase 3

Conditions: Diffuse Diabetic Macular Edema

Treatments: Procedure: Bevacizumab + Pars plana vitrectomy; Procedure: Bevacizumab + pars plana vitrectomy

Study type: Interventional

Funder types: Other

Identifiers

NCT00571142

APEC-ret

Details and patient eligibility

About

To Evaluate combined effect of vitrectomy and bevacizumab to stabilize retinal thickness and visual acuity in patients with diffuse diabetic macular edema and their relation to renal disease.

Enrollment: 20 patients

Sex: All

Ages: 25 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Older than 25 yo
• Diffuse diabetic macular edema with or without previous treatment

Exclusion criteria

• Another retinal disease
• Pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 2 patient groups

1

Active Comparator group

Description:

Renal disease

Treatment:

Procedure: Bevacizumab + Pars plana vitrectomy

2

Active Comparator group

Description:

Without renal disease

Treatment:

Procedure: Bevacizumab + pars plana vitrectomy